SCHEMBL2291776

SCHEMBL2291776

CCN1c2ccccc2Nc2c(NC(C)=O)cccc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.41
GAA P10253 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
TSHR P16473 2/20 0.40
ALDH1A1 P00352 5/20 0.40
HPGD P15428 2/20 0.40
KDM4E B2RXH2 4/20 0.39
HSD17B10 Q99714 2/20 0.39
BRD4 O60885 1/20 0.38
CREBBP Q92793 1/20 0.38
HTT P42858 2/20 0.38
TSPO P30536 1/20 0.38
CASP3 P42574 1/20 0.37
MAOA P21397 1/20 0.37
POLB P06746 2/20 0.36
CYP2C19 P33261 1/20 0.36
MAPT P10636 1/20 0.36
LMNA P02545 1/20 0.36
GLA P06280 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17187689 0.84 CYP2C19 (0.46) MAPK1GAASMN1; SMN2TSHRALDH1A1
SCHEMBL2292527 0.77 ALOX5 (0.48) GAASMN1; SMN2ALDH1A1KDM4EBRD4
Sulfuric Acid SCHEMBL29282027 0.73 GAA (0.36) GAASMN1; SMN2ALDH1A1TSPOPOLB
SCHEMBL2287889 0.73 GAA (0.48) GAASMN1; SMN2ALDH1A1HPGDKDM4E
SCHEMBL8376596 0.71 DRD2 (0.39) ALDH1A1KDM4ECYP2C19MAPTLMNA
Sulfuric Acid SCHEMBL31514469 0.70 ALDH1A1 (0.38) MAPK1GAASMN1; SMN2TSHRALDH1A1
Sulfuric Acid SCHEMBL10339576 0.70 ALDH1A1 (0.38) MAPK1GAASMN1; SMN2TSHRALDH1A1
SCHEMBL3413314 0.70 LTB4R (0.40) GAASMN1; SMN2MAPT
SCHEMBL2289464 0.70 TSPO (0.35) GAASMN1; SMN2KDM4EHTTTSPO
SCHEMBL31488339 0.70 KCNH2 (0.49) GAASMN1; SMN2TSHRALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2265726-B1 BIOSENSOR WITH IMPROVED ANALYTE SPECIFICITY ROCHE DIAGNOSTICS GMBH (DE) 2014-05-07 EP disclosed
US-8535511-B2 Methods for electrochemical analysis using matrix compositions with alkylphenazine quaternary salt and a nitrosoaniline ROCHE DIAGNOSTICS OPERATIONS, INC. (US) 2013-09-17 US disclosed
US-8008037-B2 Matrix composition with alkylphenazine quaternary salt and a nitrosoaniline ROCHE DIAGNOSTICS OPERATIONS, INC. (US) 2011-08-30 US disclosed
EP-2265726-A1 BIOSENSOR WITH IMPROVED ANALYTE SPECIFICITY Roche Diagnostics GmbH (DE) 2010-12-29 EP disclosed
WO-2009118157-A1 BIOSENSOR WITH IMPROVED ANALYTE SPECIFICITY ROCHE DIAGNOSTICS GMBH (DE) 2009-10-01 WO disclosed
US-20090246808-A1 BIOSENSOR WITH IMPROVED ANALYTE SPECIFICITY ROCHE DIABETES CARE, INC. 2009-10-01 US disclosed